Literature DB >> 15680314

Acute functional effects of cyclosporine-A and methylprednisolone treatment in adult rats exposed to transient ischemic stroke.

Cesario V Borlongan1, Guolong Yu, Noriyuki Matsukawa, Lin Xu, David C Hess, Paul R Sanberg, Yun Wang.   

Abstract

The present study examined the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats were initially subjected to transient middle cerebral artery occlusion (MCAo) then randomly assigned to one of the following treatment conditions: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle exhibited significant cognitive impairments, as revealed by passive avoidance and Morris water maze tasks, at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal cognitive performance throughout the test period. Ischemic animals that received low dose CsA plus MP also showed significantly less cognitive deficits but such attenuation of stroke-induced behavioral impairments was only consistently reflected in the passive avoidance task, while performance in the Morris water maze task deteriorated over time. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. These observations suggest that despite overt cerebral damage, alterations in simple, but not complex, cognitive tasks produced by MCAo could be ameliorated by low dose CsA when combined with MP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15680314     DOI: 10.1016/j.lfs.2004.09.022

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Authors:  Michel Modo
Journal:  J Exp Stroke Transl Med       Date:  2009-01

2.  Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains.

Authors:  Austin C Boese; Auston Eckert; Milton H Hamblin; Jean-Pyo Lee
Journal:  Exp Neurol       Date:  2020-03-05       Impact factor: 5.330

3.  Cyclosporin A ameliorates eclampsia seizure through reducing systemic inflammation in an eclampsia-like rat model.

Authors:  Qian Huang; Bihui Hu; Xinjia Han; Jinying Yang; Xiaodan Di; Junjie Bao; Huishu Liu
Journal:  Hypertens Res       Date:  2020-01-14       Impact factor: 3.872

4.  Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow.

Authors:  Atsushi Nagai; Woo K Kim; Hong J Lee; Han S Jeong; Kwang S Kim; Seok H Hong; In H Park; Seung U Kim
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

5.  Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines.

Authors:  Naoki Tajiri; David M Quach; Yuji Kaneko; Stephanie Wu; David Lee; Tina Lam; Ken L Hayama; Thomas G Hazel; Karl Johe; Michael C Wu; Cesar V Borlongan
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

6.  Cyclosporine A Treatment Abrogates Ischemia-Induced Neuronal Cell Death by Preserving Mitochondrial Integrity through Upregulation of the Parkinson's Disease-Associated Protein DJ-1.

Authors:  Naoki Tajiri; Cesar V Borlongan; Yuji Kaneko
Journal:  CNS Neurosci Ther       Date:  2016-06-01       Impact factor: 5.243

Review 7.  Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke.

Authors:  Shohei Matsumoto; Michihiro Murozono; Masahiro Kanazawa; Takeshi Nara; Takuro Ozawa; Yasuo Watanabe
Journal:  Acute Med Surg       Date:  2018-05-17

8.  Cyclosporin A ameliorates cerebral oxidative metabolism and infarct size in the endothelin-1 rat model of transient cerebral ischaemia.

Authors:  Axel Forsse; Troels Halfeld Nielsen; Kevin Heebøll Nygaard; Carl-Henrik Nordström; Jan Bert Gramsbergen; Frantz Rom Poulsen
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

9.  Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review.

Authors:  I A Mulder; E T van Bavel; H E de Vries; J M Coutinho
Journal:  Fluids Barriers CNS       Date:  2021-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.